Concepedia

Koji Chono

KC

13

Publications

487

Citations

12

H-Index

2002

Active since

Affiliations

Astellas Pharma (Japan)(Current)

University of Toyama

Toho University

Hokkaido University

Koji Chono is an author at Astellas Pharma (Japan) specializing in medicine, virology, and herpesviruses.

Top concepts

Publications per year

2002–2020

13

Publications

13

ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2

Koji Chono, Kiyomitsu Katsumata, Toru Kontani et al. · Journal of Antimicrobial Chemotherapy · 2010 · 158 citations · Full text

The early snail acquires the learning. Comparison of scores for conditioned taste aversion between morning and afternoon

Akiko Wagatsuma, Rio Sugai, Koji Chono et al. · Acta Biologica Hungarica · 2004 · 50 citations

, , +14

Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus

Koji Chono, Kiyomitsu Katsumata, Hiroshi Suzuki et al. · Antiviral Research · 2012 · 36 citations

, , +9

Characterization of virus strains resistant to the herpes virus helicase–primase inhibitor ASP2151 (Amenamevir)

Koji Chono, Kiyomitsu Katsumata, Toru Kontani et al. · Biochemical Pharmacology · 2012 · 33 citations

, , +10

The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin

Tetsuo Yamaguchi, Hiroe Konishi, Kotaro Aoki et al. · Journal of Infection and Chemotherapy · 2020 · 31 citations

Rows per page

1–5 of 13